These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
319 related articles for article (PubMed ID: 20032800)
1. False-positive F-18 FDG uptake in PET/CT studies in pediatric patients with abdominal Burkitt's lymphoma. Riad R; Omar W; Sidhom I; Zamzam M; Zaky I; Hafez M; Abdel-Dayem HM Nucl Med Commun; 2010 Mar; 31(3):232-8. PubMed ID: 20032800 [TBL] [Abstract][Full Text] [Related]
2. 18F-FDG PET and PET/CT in Burkitt's lymphoma. Karantanis D; Durski JM; Lowe VJ; Nathan MA; Mullan BP; Georgiou E; Johnston PB; Wiseman GA Eur J Radiol; 2010 Jul; 75(1):e68-73. PubMed ID: 19716248 [TBL] [Abstract][Full Text] [Related]
3. Prognostic values of interim and post-therapy 18F-FDG PET/CT scanning in adult patients with Burkitt's lymphoma. Wei WX; Huang JJ; Li WY; Zhang X; Xia Y; Jiang WQ; Fan W; Li ZM Chin J Cancer; 2015 Dec; 34(12):608-13. PubMed ID: 26630874 [TBL] [Abstract][Full Text] [Related]
4. [Value of Pretherapeutic Ding CY; Liu HY; Guo Z; Li TN Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Apr; 25(2):438-443. PubMed ID: 28446289 [TBL] [Abstract][Full Text] [Related]
5. Hodgkin disease: diagnostic value of FDG PET/CT after first-line therapy--is biopsy of FDG-avid lesions still needed? Schaefer NG; Taverna C; Strobel K; Wastl C; Kurrer M; Hany TF Radiology; 2007 Jul; 244(1):257-62. PubMed ID: 17581905 [TBL] [Abstract][Full Text] [Related]
6. 18F-FDG PET in malignant lymphoma: significance of positive findings. Castellucci P; Zinzani P; Pourdehnad M; Alinari L; Nanni C; Farsad M; Battista G; Tani M; Stefoni V; Canini R; Monetti N; Rubello D; Alavi A; Franchi R; Fanti S Eur J Nucl Med Mol Imaging; 2005 Jul; 32(7):749-56. PubMed ID: 15785956 [TBL] [Abstract][Full Text] [Related]
7. Predictive value of (18)F-FDG hybrid PET/CT for the clinical outcome in patients with non-Hodgkin's lymphoma prior to and after autologous stem cell transplantation. Qiao W; Zhao J; Wang C; Wang T; Xing Y Hematology; 2010 Feb; 15(1):21-7. PubMed ID: 20132658 [TBL] [Abstract][Full Text] [Related]
8. Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients. Kanzaki R; Higashiyama M; Maeda J; Okami J; Hosoki T; Hasegawa Y; Takami M; Kodama K Interact Cardiovasc Thorac Surg; 2010 Jun; 10(6):1009-14. PubMed ID: 20197344 [TBL] [Abstract][Full Text] [Related]
9. False-Positive [18F]fluorodeoxyglucose-avid lymph nodes on positron emission tomography-computed tomography after allogeneic but not autologous stem-cell transplantation in patients with lymphoma. Ulaner GA; Lilienstein J; Gönen M; Maragulia J; Moskowitz CH; Zelenetz AD J Clin Oncol; 2014 Jan; 32(1):51-6. PubMed ID: 24248697 [TBL] [Abstract][Full Text] [Related]
10. Spectrum of FDG PET/CT findings in Burkitt lymphoma. Zeng W; Lechowicz MJ; Winton E; Cho SM; Galt JR; Halkar R Clin Nucl Med; 2009 Jun; 34(6):355-8. PubMed ID: 19487844 [TBL] [Abstract][Full Text] [Related]
11. 18F-FDG PET for evaluation of the treatment response in patients with gastrointestinal tract lymphomas. Kumar R; Xiu Y; Potenta S; Mavi A; Zhuang H; Yu JQ; Dhurairaj T; Dadparvar S; Alavi A J Nucl Med; 2004 Nov; 45(11):1796-803. PubMed ID: 15534046 [TBL] [Abstract][Full Text] [Related]
12. Fluorodeoxyglucose positron emission tomography (FDG-PET) and PET/computed tomography imaging characteristics of thyroid lymphoma and their potential clinical utility. Basu S; Li G; Bural G; Alavi A Acta Radiol; 2009 Mar; 50(2):201-4. PubMed ID: 19089692 [TBL] [Abstract][Full Text] [Related]
13. 18F-FDG PET/CT in evaluating non-CNS pediatric malignancies. Tatsumi M; Miller JH; Wahl RL J Nucl Med; 2007 Dec; 48(12):1923-31. PubMed ID: 18056332 [TBL] [Abstract][Full Text] [Related]
14. The role of FDG-PET/CT in the evaluation of residual disease in paediatric non-Hodgkin lymphoma. Bhojwani D; McCarville MB; Choi JK; Sawyer J; Metzger ML; Inaba H; Davidoff AM; Gold R; Shulkin BL; Sandlund JT Br J Haematol; 2015 Mar; 168(6):845-53. PubMed ID: 25382494 [TBL] [Abstract][Full Text] [Related]
16. (18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. Lopci E; Burnelli R; Ambrosini V; Nanni C; Castellucci P; Biassoni L; Rubello D; Fanti S Cancer Biother Radiopharm; 2008 Dec; 23(6):681-90. PubMed ID: 19111053 [TBL] [Abstract][Full Text] [Related]
17. 18F-FDG PET early after radiotherapy in lymphoma patients. Castellucci P; Zinzani P; Nanni C; Farsad M; Moretti A; Alinari L; Battista G; Pettinato C; Marengo M; Boschi S; Canini R; Baccarani M; Monetti N; Fanti S Cancer Biother Radiopharm; 2004 Oct; 19(5):606-12. PubMed ID: 15650453 [TBL] [Abstract][Full Text] [Related]
18. Utility of 18F-FDG PET/CT for staging NK/T-cell lymphomas. Wu HB; Wang QS; Wang MF; Li HS; Zhou WL; Ye XH; Wang QY Nucl Med Commun; 2010 Mar; 31(3):195-200. PubMed ID: 20009963 [TBL] [Abstract][Full Text] [Related]
19. Role of 18F-FDG-PET/CT in the management of Burkitt lymphoma. Carrillo-Cruz E; Marín-Oyaga VA; Solé Rodríguez M; Borrego-Dorado I; de la Cruz Vicente F; Quiroga Cantero E; Manzanares Pérez M; Capote FJ; Ramírez Sánchez MJ; Espigado Tocino I; Pérez-Vega H; Vázquez-Albertino R; Pérez-Simón JA Eur J Haematol; 2015 Jan; 94(1):23-30. PubMed ID: 24520874 [TBL] [Abstract][Full Text] [Related]
20. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas. Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]